JAVMA news
FTC pushes for more competition in pet medications market
The Federal Trade Commission released a report in May finding that veterinarians will continue to face increasing competition from nonveterinary…
JAVMA news
Company takes canine cancer drug off market to study dosing
Oasmia Pharmaceutical AB has taken a canine cancer drug, Paccal Vet, or paclitaxel for injection, off the market to study lowering the
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
JAVMA news
Assessing pet supplements
A third of all U.S. households with dogs use supplements, as do about a fifth of households with cats, according to a report on pet supplements from…
JAVMA news
DEA provides update on opioid shortage
The Drug Enforcement Administration released a statement April 10 on the ongoing opioid shortages affecting both human and veterinary medicine.
JAVMA news
More opioids available to veterinarians during ongoing shortage
The Food and Drug Administration announced Dec. 13 that the agency has worked with Pfizer Inc. to help alleviate a shortage of certain injectable…
Cannabis: FAQs for veterinarians
Get answers to frequently asked questions about the regulatory status of cannabis, cannabis-derived, and cannabis-related products in veterinary…
JAVMA news
FDA warns companies illegally selling CBD products
Agency signaled that it cannot conclude cannabidiol is safe.
JAVMA news
Supplement companies made changes after facing crackdown
The availability of glucosamine for animals seemed to be in question 15 years ago.
JAVMA news
New law supports FDA approval of more animal drugs
A new federal law includes language to expand conditional approval of animal drugs beyond minor uses and minor species,
JAVMA news
Generic drugs, skyrocketing prices
Over the years, generic prescription drugs approved for use in humans have provided tremendous savings in human and veterinary medicine alike.
Over-the-counter antimicrobials changing to prescription-only
The FDA has outlined its process for changing certain medically important antimicrobial drugs from over-the-counter (OTC) to prescription (Rx). Rx…
JAVMA news
FDA finalizes guidance on cell-based products in animals
The Food and Drug Administration issued final guidance June 11 on the agency’s current thinking about how existing regulations apply
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
JAVMA news
FDA issues guidance on regulation of cell-based products in animals
The Food and Drug Administration has issued draft guidance on the agency’s current thinking about how existing regulations apply to the use of…
blog
Medically important antibiotics to move from OTC to Rx
By June 2023, all medically important antibiotics will require veterinary oversight to be used in animals, even if the animals are not intended for…
JAVMA news
Large animal practitioners grapple with fluid shortage
Large animal practitioners are grappling with a shortage of large-volume bags of polyionic fluids, separate from the ongoing shortage
Compounding from bulk drug substances
Learn about GFI #256, which clarifies the circumstances under which FDA does not intend to pursue enforcement action for compounding animal drugs from…
JAVMA news
Cannabis research for veterinary patients advancing, cautiously
More than half the country has legalized marijuana use in one form or another.
JAVMA news
FDA’s Dunham delves into drug issues
Dr. Bernadette Dunham, director of the Food and Drug Administration’s Center for Veterinary Medicine, recently fielded questions about drug issues and…